Hyperuricemia in Type 2 Diabetes Mellitus
Keywords:
type 2 diabetes mellitus, plasma uric acid, ada, 5'-nucleotidase
Abstract
Abstract not found
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
References
R. Kashinath (1972) Whole blood uric acid levels in diabetics with or without lipaemia. J. Mys. Med. 36, 153-156.
Kertes J, Jhonson M (2007) Evidence based Eye care.
Butturini U, Coscelli I (1977) Insulin release in hyperuricemic patients. Acta. Diabetol. 14, 73-78.
D. Sinagra, D. Greco, A. Scarpitta (1996) Serum uric acid, insulin secretion and resistance in non-hyperuricemia and hyperuricemic obese female subjects. Int. J. Obes. Relat. 20, 1041-1043.
M. Wang, O. Zhao, Wang Lin, J. Lin, S. (2007) A prospective study on relationship between blood uric acid levels, insulin sensitivity and insulin resistance. 46, 824-826.
G. Quinones, A. Natali, S. Baldi, S. Frascerra, G. Sanna, D. Ciociaro, etal (1995) Effect of insulin on uric acid excretion in humans. 268, 1-E5.
J. Medelie, C. Papier, U. Goldbourt, J. Herman (1975) Major factors in the development of diabetes mellitus in 10000 men. 135, 811-17.
Herman B, Medelie U (1976) Diabetes, prediabetes and uricaemia. 12(1), 47-52. https://doi.org/10.1007/bf01221964
Toumilehto J, Zimmet P, Wolf E, Taylor R, Ram P, King H (1988) PLASMA URIC ACID LEVEL AND ITS ASSOCIATION WITH DIABETES MELLITUS AND SOME BIOLOGIC PARAMETERS IN A BIRACIAL POPULATION OF FIJI. 127, 321-336.
N. Nakanishi, M. Okamoto, H. Yoshida, Y. Matsuo, K. Suzuki, K. Tatara (2003) Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur. J. 18, 523-530.
E. Boyko, M. de Courten, P. Zimmer P Z, Chitson, K. TonmilhetoJ&Alberti (2000) Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance - a prospective study in Maurtius. 23, 1242-1248.
Dehgan A, Von M, Sjibrands G, Hofman M (2008) High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes. 31(2), 361-362.
Chein L, Chan E, Hsu etal (2008) Plasma Uric Acid and the Risk of Type 2 Diabetes in a Chinese Community. 54, 310-316.
Kramer K, Van D (2009) Serum Uric Acid Levels Improve Prediction of Incident Type 2 Diabetes in Individuals With Impaired Fasting Glucose: The Rancho Bernardo Study. 32(10), e126-e126. https://doi.org/10.2337/dc09-1358
Saih Kodama S, Yachi etal (2009) Association Between Serum Uric Acid and Development of Type 2 Diabetes. 32(9), 1737-1742.
M. Modan, H. Halkin, A. Karasik, A. Lusky Elevated serum uric acid ? a facet of hyperinsulinaemia. 30(9), 713-718.
Pavani Shankar (2011) Association between serum uric acid levels and diabetes mellitus. 2011, 1-6.
Feldman Jerome, &heroldlebrovitz (1971) 19(2), 474.
Cited in Practical Clinical Biochemistry by Herold Varley, 4th Edn. 82-83.
T. Caraway (1967) cited in Practical Clinical Biochemistry by Herold Varley, 3rdEdn, page :205.
Giusti G (1974) Estimation of adinosinedeaminase cited in Methods of enzymatic analysis. 2, 1092-1099.
E. Campbell (1967) cited in Practical Clinical Biochemistry by Herold Varley, 3rdEdn. 1, 465-466.
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. 414, 813-820.
L. Ronald, Huey Jenkins, Stanley McDaneil, Wayne Digerness, &. Parrish, L. Richard, Ong (1988) Adenine nucleotide metabolism in hearts of diabetic rats. 37, 629-636.
Warrior C, Rao Y, Kulpati S (1995) Evaluation of adenosine deaminase activity and lipid peroxidation levels in diabetes mellitus. 10(1), 9-13. https://doi.org/10.1007/bf02873661
M. Goen, H. Sirajwala, J. Kalaria (2013) A study of serum adenosoinedeaminaselevels in patients with type 2 diabetes mellitus and its correlation with glycemic control. Ind. J. Med. App. 2(3), 259-267.
N. Kurtel, S. Pence, E. Akarsu, etal (1977) Adenosine deaminase activity in lymphocytes. 37, 157-158.
Brein M, Granner K (1991) Regulation of gene expression by insulin. 278, 609-619.
Mahdev K, Zilbering A, Zhu L, Goldstein J (2001) Insulin-stimulated Hydrogen Peroxide Reversibly Inhibits Protein-tyrosine Phosphatase 1B in Vivo and Enhances the Early Insulin Action Cascade. 276, 1938-2194.
Meng C, Fukuda NK (2002) Reversible Oxidation and Inactivation of Protein Tyrosine Phosphatases In Vivo. 9, 387-389.
Meng C, Buckley DA, Galic S, Tiganis NK (2004) Regulation of insulin signaling through reversible oxidation of the protein tyrosine phosphatases TC 45 and PTP1B. J.Biol. 279, 7716-3772.
Zengchang Hairong Nan, WeignoGao Shaojie Wang, JieRen LeiZang, Jakko Feng Ning, Qing Qiao (2010) Diabetes & Vascular Disease Research. 7(1), 40-46.
M. SudhindraRao, John Sahayo (2012) A study of Serum uric acid in diabetes mellitus and pre-diabetes in a south Indian tertiary care hospital. 2(2), 18-23.
Abdul Jalai, Safi, Rashid Mohmood, Mudassir Ahmed Khan &Amin-ul-Haq (2004) Association of Serum uric acid with type 2 diabetes mellitus. 18(1), 59-63.
Clark D, &Stoerk HC (1956) The uptake of P32 by nucleic acids of Lymphoid tissue undergoing atrophy. J. Biol. 222, 285-292.
P. Fao, G. Galasino, E. Costa (1955) Prolactin and secretion of insulin and glucagon by the pancreas. 182, 493-496.
Published
2014-03-31
Issue
Section
License
Copyright (c) 2014 Authors and Global Journals Private Limited

This work is licensed under a Creative Commons Attribution 4.0 International License.